What Low Testosterone Does to Women Doctors Never Check

Low testosterone in women often causes persistent fatigue, low sexual desire, reduced muscle strength, and mood or memory changes that get mislabeled as stress or depression, since no standard testing range exists and most doctors never check for it, though licensed therapists can help address the emotional impact and guide next steps.

What if your endless fatigue and vanished sex drive aren't stress, aging, or depression, but a hormone almost no doctor thinks to test? Low testosterone in women rarely gets checked, yet it can quietly reshape your energy, mood, and desire. Here's why it's missed, and what finally getting answers looks like.

What testosterone actually does in a woman’s body

Testosterone is usually described as a male hormone, but that framing is inaccurate. The ovaries and adrenal glands produce it in women too, just in much smaller amounts than in men, and it is a normal part of how the female endocrine system functions throughout life, according to Mayo Clinic’s overview of testosterone in women. Testosterone belongs to a broader group of hormones called androgens. Cleveland Clinic explains that androgens are produced by the ovaries and adrenal glands in women and support bone health, red blood cell production, and reproductive function in both sexes, not just male physical traits.

In women, testosterone contributes to sexual desire and arousal, along with muscle maintenance, bone density, steady energy, and mood stability, per the same Mayo Clinic source. Levels do not fall off a cliff at any single point. They decline gradually across the lifespan, with midlife levels lower than they were in a woman’s twenties and thirties, the same source notes.

A few terms matter for understanding low testosterone in women. Total testosterone is the full amount circulating in the blood. Free testosterone is the portion not attached to proteins, meaning it is available for the body’s tissues to actually use. Sex hormone binding globulin, or SHBG, is the protein that binds most testosterone and keeps it inactive, which is why a high total number can still coexist with low usable hormone.

There is no single, universally agreed reference range for what counts as normal or low in women, and that gap shapes how female androgen deficiency gets discussed, tested, and often dismissed. Hormonal shifts of this kind can also intersect with broader women’s mental health concerns, since mood and hormone regulation are closely linked.

What low testosterone does to women

Low testosterone in women rarely shows up as one clear signal. Instead it collects as a set of changes across sex, energy, and mood that each seem small enough to explain away on their own. The symptoms of low testosterone in women tend to overlap so heavily with ordinary tiredness or a bad stretch of life that most women describe the pattern for years before anyone names it.

Sexual desire and arousal changes

The most consistent complaint is a flat, absent interest in sex that feels different from being tired or annoyed at a partner. It is not reluctance tied to a specific person or a specific week. Research on androgen deficiency in women describes decreased sexual desire alongside reduced genital arousal, blunted orgasmic response, and decreased vaginal lubrication, all occurring together rather than as isolated complaints. Women often notice the physical side before they can put words to it: touch that used to register barely registers at all.

Energy, strength, and body composition

The fatigue that comes with low testosterone does not respond to more sleep. Women describe a heaviness in ordinary tasks and a harder time holding onto muscle despite training the same way they always have. The same research on androgen deficiency in women links this to measurable muscle weakness, not just a subjective sense of being run down. That distinction matters because it means the fatigue has a physical basis, even when nothing on the surface looks wrong.

What are the symptoms of low testosterone in women? Mood, motivation, and mental clarity

The symptoms of low testosterone in women often center on a dulled, greyed-out mood rather than sadness itself. Motivation drops first, and concentration or word-finding complaints follow, the sense of reaching for a word that used to come easily. A study on testosterone and cognitive function in women found that lower testosterone levels tracked with worse global cognition, processing speed, and verbal memory in a specific group of women. Because the loss reads as drive disappearing rather than mood collapsing, it gets labeled depression more often than it gets recognized for what it is, a pattern that also shows up under the umbrella of perimenopausal depression.

Beyond these three areas, women report bone and joint aches, thinning hair, dry skin, and disrupted sleep, symptoms that get filed under aging or stress long before hormones come up. None of these symptoms points to testosterone on its own. What makes the picture worth noticing is the whole cluster arriving together, not any single complaint standing alone.

Why testosterone drops in women

Testosterone in women declines gradually with age, and that decline starts well before the hormonal shifts of menopause. Ovaries and adrenal glands both produce androgens throughout adulthood, and output from both sources tends to taper years ahead of a woman’s final period. This means a woman in her thirties can already be living with lower levels than she had in her twenties, with no obvious event marking the change. There are many causes of low testosterone in women, and age on its own is one of the most common.

Surgical removal of the ovaries, known as oophorectomy, produces a much more abrupt drop than natural menopause. Where natural menopause involves a gradual tapering, surgical removal cuts off ovarian hormone production immediately. Cleveland Clinic notes that this kind of surgical menopause is one of the recognized causes of low testosterone in women, alongside natural aging.

Less commonly, conditions affecting the adrenal glands or the pituitary gland reduce androgen production upstream, since both organs help regulate the signals that tell the ovaries and adrenal cortex how much hormone to make. Certain medical conditions and treatments also raise a protein called SHBG, or sex hormone binding globulin, which binds to testosterone in the bloodstream and lowers the amount that is free and biologically active. Oral estrogen-containing contraceptives and some thyroid conditions are documented to raise SHBG this way, as a matter of pharmacology rather than personal circumstance.

Chronic stress, severe calorie restriction, overtraining, and chronic illness can also suppress androgen production, since the body treats sustained physical or psychological strain as a signal to conserve resources. Pregnancy and breastfeeding bring their own hormonal shifts, and testosterone levels often sit lower during this window before gradually returning to a woman’s baseline.

Low testosterone or something else? A side-by-side comparison

Low testosterone shares symptoms with several common conditions, which is exactly why it gets missed. The difference between low testosterone and other hormonal issues in women often comes down to which symptoms travel together and which ones show up alone. A side-by-side look makes the pattern easier to spot.

Low testosterone shows up as a flat, absent desire and drive, with none of the hot flushes or cycle changes that mark perimenopause. Perimenopause brings irregular periods, night sweats, and mood swings tied to fluctuating estrogen. Hypothyroidism adds cold intolerance, constipation, and reflexes that feel slowed down, on top of fatigue. Depression involves a loss of pleasure and interest across the board, not just in sex, along with guilt, worthlessness, or hopelessness that low libido alone does not produce.

What a workup looks at differs too. Perimenopause is typically read through cycle history and estrogen-related symptoms. Hypothyroidism is checked with thyroid-stimulating hormone and related blood markers. Depression is assessed through mood, interest, sleep, and energy over time, sometimes alongside conditions like perimenopausal depression, where hormonal shifts and depressive symptoms overlap directly. Low testosterone has no equivalent routine check built into most workups at all.

Low testosterone vs perimenopause

The overlap is real: both can bring fatigue, low mood, and a dip in sex drive. Perimenopause carries its own signature, irregular or skipped periods, hot flushes, and night sweats, driven by shifting estrogen. Low testosterone vs perimenopause often comes down to the cycle itself. If periods are still regular and desire has quietly disappeared without the hot flushes, that points away from perimenopause alone.

Low testosterone vs thyroid problems

Hypothyroidism and low testosterone both bring fatigue and a flattened mood. What sets thyroid dysfunction apart is the cluster around it: feeling cold when others do not, constipation, dry skin, and reflexes that feel sluggish. Low testosterone does not typically bring that physical slowdown. It tends to sit more narrowly around desire, drive, and a sense of flatness.

Low testosterone vs depression

Depression touches everything, not just sex. Someone experiencing depression tends to lose interest in food, hobbies, and people, and often carries guilt or hopelessness that has nothing to do with libido. Low testosterone narrows in on desire and drive while leaving general interest and mood regulation more intact. These conditions frequently coexist rather than compete, so identifying depression does not rule out low testosterone, and finding one explanation does not mean the search should stop there.

The practical problem is sequencing. The cheapest, most familiar explanation usually gets tested first, and low testosterone is neither cheap nor familiar to most clinicians ordering routine labs.

How low testosterone is tested in women, and why it usually is not

What a testosterone workup for women actually measures

A testosterone workup for women typically includes total testosterone, free or calculated free testosterone, and sex hormone binding globulin (SHBG), usually drawn in the morning when levels are most stable. Total testosterone counts everything in the blood, including hormone bound to proteins. Free testosterone is the small, biologically active fraction not attached to those proteins, which is why the two numbers get tested separately. SHBG matters because it controls how much testosterone stays bound versus free, so a normal total number can still sit alongside very little usable hormone.

Why is low testosterone almost never checked in women?

Low testosterone is almost never checked in women because the tools built to measure it were designed for a different body. Standard immunoassays were calibrated for male-range concentrations, and they lose accuracy at the much lower levels typical in women, which means a result can look precise while telling the clinician very little. On top of that, there is no agreed number that marks the line between normal and deficient. The Endocrine Society’s clinical practice guideline recommends against diagnosing androgen deficiency in otherwise healthy women, specifically because no well-defined syndrome exists and androgen levels do not reliably predict who has symptoms or who responds to treatment. That guidance is a defensible response to genuinely poor assays, and it also means a woman can ask for testosterone testing for women and be told there is no reliable way to interpret the answer.

What gets tested instead

When a woman reports fatigue and low libido, the workup that follows often looks elsewhere entirely. A thyroid panel, iron and ferritin levels, vitamin D, and a depression screen are common substitutes, each checking for a condition with a clearer diagnostic cutoff than anything testosterone offers. These are reasonable tests to run. The problem is that they can all come back normal while the original complaint goes unexplained, because they were never designed to capture what testosterone might be doing.

Making the conversation more productive

How do doctors test for low testosterone in women, and what makes that conversation go further than a shrug? Time pressure in a short visit, a tendency to read sexual symptoms as relationship or mood issues, and the lack of a clear next step if a number comes back low all make ordering the test less likely. A few things tend to move the conversation forward anyway: bringing a written timeline of symptoms, naming the specific change (low desire, loss of muscle, persistent fatigue) instead of a general “I’m tired,” and asking directly what would be measured and what the result would actually change. That last question matters most, since a test only helps if an answer, in either direction, leads somewhere.

Why women’s hormone research lags, and what that costs patients

Testosterone research began with male physiology as the default subject. Dosing ranges, normal reference values, and even the outcome measures used to judge whether a treatment worked were built around men’s bodies first. Female-specific data arrived decades later, and in many cases it still has not arrived in a form clinicians can act on with confidence.

Part of this comes down to incentive. The Global Consensus Position Statement on the Use of Testosterone Therapy for Women notes that no testosterone product has been approved for women in most markets, which means there has been little commercial reason to fund the large trials that would establish clear ranges for female androgen deficiency. Without an approved product, there is no company with a financial stake in proving a dose works. The trials that would answer the basic questions women’s hormone research still has not settled simply were not built.

There is also a history of where symptoms got filed. Low libido, fatigue, and low mood in women were long treated as psychological concerns rather than endocrine ones, and that framing shaped which studies got funded and which did not. A symptom sorted into the wrong category rarely gets the lab work that might explain it.

The result lands on the patient. Symptoms that are real but unmeasurable by any agreed standard leave a clinician with no protocol to reach for, not because the clinician is dismissive, but because the field never built one. Understanding that this is a structural gap, not a personal failing, matters most for the woman who has already been told nothing is wrong. The absence of a number does not mean the absence of a cause.

What treatment for low testosterone in women involves

What are the best treatments for low testosterone in women?

There is no testosterone product built and approved specifically for women, so treatment in practice usually means low doses of formulations made for men, or a compounded version mixed by a pharmacy to a custom strength. A systematic review and meta-analysis of 36 randomized controlled trials found that non-oral testosterone, meaning patches or creams applied to the skin, produced neutral effects on cholesterol, while oral testosterone raised LDL and lowered HDL and triglycerides. That difference is a large part of why transdermal routes are the ones most studied and most used in women, and why oral androgens are generally avoided. Compounded preparations are not held to the same manufacturing oversight as approved products, and strength can vary between batches, which the same body of research flags as an ongoing concern.

What the evidence supports, and where it runs out

The strongest evidence sits behind one outcome: sexual desire in postmenopausal women. Research on androgen therapy in women shows that most placebo-controlled trials found improved sexual function with low-dose testosterone in carefully selected postmenopausal women diagnosed with hypoactive sexual desire disorder. The same meta-analysis on testosterone in postmenopausal women found improvements in desire, arousal, and satisfaction, alongside more acne and hair growth, but no measurable change in body composition or cognition. Evidence for fatigue, mood, and mental clarity is thinner and less consistent, which is worth knowing before treatment is framed as a fix for those symptoms.

How treatment is typically approached and reviewed

Treatment is generally handled as a defined trial with a review point, not an open-ended decision. Symptom change carries more weight than the number on a lab report, since levels and how someone feels do not always move together.

Non-hormonal and psychological support that runs alongside

Several things run in parallel regardless of what happens with hormones: resistance training, attention to sleep and recovery, and correcting iron or thyroid findings that can produce overlapping fatigue. Where low desire has become tangled with conflict, avoidance, or shame, sex therapy or couples work can separate a desire problem from a relationship problem. Therapy also has a place in processing what it feels like to be disbelieved by a clinician, and in rebuilding a sense of agency over a body that has felt unreadable. Approaches like cognitive behavioral therapy and interpersonal therapy both have a role here, depending on whether the harder part is the thought patterns or the relationship dynamics involved.

If the experience of not being taken seriously has worn you down, or low desire has become tangled up with your relationship, you can create a free ReachLink account and browse licensed therapists at your own pace, with no commitment. Guidance specific to your own situation has to happen in person, with someone who can see your full history.

Risks, monitoring, and the questions worth tracking

Testosterone therapy risks in women are documented mainly at supraphysiologic exposure, meaning doses well above what the female body typically produces. At those levels, the British Menopause Society’s clinical guidance on testosterone replacement in menopause notes reported effects including acne, increased facial or body hair, scalp hair thinning, and voice changes that may not fully reverse. The same guidance describes these effects as uncommon at physiological doses, and most are reversible when they do occur. Long-term cardiovascular and breast safety data in women remains limited. A randomized, placebo-controlled trial of testosterone dosing in women with low testosterone found no adverse changes in cardiovascular risk markers over 24 weeks, but that window is short, and the same trial’s authors point to the need for longer follow-up.

Monitoring generally means symptom review at set intervals alongside periodic labs, watching for signs of excess rather than aiming for a specific number. The literature urges particular caution during pregnancy and breastfeeding, and for anyone with a personal history of hormone-sensitive cancer.

A short log kept daily or weekly, tracking energy, desire, mood, sleep, and strength, turns a vague sense that something is off into a pattern with dates attached. That record is harder to wave away than a verbal description offered on the spot in an appointment. Noting what changed and when gives any clinician something concrete to work from.

Some changes warrant prompt attention rather than watching and waiting: rapid voice deepening, significant hair loss, or a new and severe shift in mood. These are not symptoms to track quietly over months.

Your fatigue and low desire deserve a real answer, not a shrug

Living with symptoms that get waved away as stress, aging, or moodiness wears on you in ways that are hard to name. You know your own body, and being told repeatedly that everything looks normal does not make the exhaustion or the disconnection from yourself any less real. That gap between what you feel and what gets taken seriously is its own kind of weight to carry.

You do not need to have the right vocabulary for what is happening in your body before you ask for support. Talking to someone who listens without rushing to a tidy explanation can help you sort through what is physical, what is emotional, and where those two things meet. You can begin with a free assessment at ReachLink, at whatever pace feels manageable, with no commitment beyond that first step: https://app1.reachlink.com/auth/register.